Company N ame: M arkel Corp
Company Ticker: M K L US Equity
Date: 2012-08-09

Q2 2012 Earnings Call
Company Participants
FINAL

Anne Waleski, Chief Financial Officer
Michael Crowley, Co-President
Richie Whitt, Co-President
Tom Gayner, President

Other Participants
Adam Klauber, Analyst
David West, Analyst
Jay Cohen, Analyst
Mark Hughes , Analyst
Meyer Shields , Analyst
Ron Bobman, Analyst
Scott Heleniak, Analyst

Bloomberg Transcript

Presentation
Operator
Greetings and welcome to the Markel Corporation Second Quarter 2012 earnings call. At
this time, all participants are in a listen-only mode. A brief question-and-answer session
will follow the formal presentation.
(Operator Instructions).
As a reminder, this conference is being recorded. It is now my pleasure to introduce your
host, Mr. Tom Gayner, President of Markel Corporation. Thank you, Mr. Gayner, you may
begin.

Tom Gayner

{BIO 1896932 <GO>}

Thank you, Manny, I appreciate it. Good morning. Welcome everyone to the Markel
Corporation Second Quarter conference call. We are pleased that you are joining us as
we all look forward to sharing the good news of our substantial year-to-date progress in
2012 in building the value of your Company.
Over the past several years we've been telling you about the transformation underway at
Markel. We've told you about the growth of our insurance operations through entry into

Page 1 of 21



Company N ame: M arkel Corp
Company Ticker: M K L US Equity
Date: 2012-08-09

FINAL

new geographical areas, our new products, and our acquisitions. We have told you about
our focus on improving the operating efficiencies in our business and how we have
restructured the Company to increase our revenues from existing customers. We have
also told you about our expanded investment activities through Markel Ventures, which
now owns controlling interest in about a dozen profitable manufacturing and service
businesses.
We've told about you how Markel has more ways and more flexibility to create value for
our shareholders than ever before. And it is now delightful to begin to show you the fruits
of these efforts rather than just telling you about them. As is our custom, our Chief
Financial Officer, Anne Waleski, will lay out the overall numbers from the first half and then
my Co-Presidents, Mike Crowley and Richie Whitt, will discuss our domestic and
international insurance activities. I will then cover our investment in Markel Ventures'
operations and then we will open the floor for your questions.

Bloomberg Transcript

Before getting started with today's line-up though, the rules say we need to repeat the
Safe Harbor Statement, so here goes. During our call today, we may make forwardlooking statements. Additional information about factors that could cause actual results to
differ materially from those projected in the forward-looking statements is described
under the captions Risk Factors and Safe Harbor and Cautionary Statements in our most
recent annual report on form 10-K and quarterly report on Form 10-Q.
We may also discuss certain non-GAAP financial measures in the call today. You may find a
reconciliation to GAAP of these measures on our website at www.Markelcorp.com in the
Investor Information section under Non-GAAP Reconciliation or in our quarterly report on
Form 10-Q. With that, Anne?

Anne Waleski

{BIO 16735457 <GO>}

Think you Tom and good morning everyone. Before I get to a discussion of our financial
results I will point out a couple of accounting items new to the quarter and the year. First,
I'm sure you have all noticed some changes in our statements for the quarter.
Redeemable Noncontrolling Interest is a new-line item on the balance sheet this quarter.
For all periods presented, we have reclassified amounts previously included in the
noncontrolling interest balances for relevant Markel Ventures affiliates to this new line
item. This is required because some of the Markel Ventures minority shareholders have
the option to sell their shares to us in the future, generally at a fixed multiple of EBITDA.
In addition to the reclassification, there is an adjustment recorded on these redeemable
noncontrolling interest balances. As of the end of each reporting period, the carrying
value of the redeemable noncontrolling interest is adjusted to the calculated redemption
value if that price is higher than the current carrying value. The purpose of these
estimates is to record the potential cash obligations we may have to the noncontrolling
interest shareholders.

Page 2 of 21



Company N ame: M arkel Corp
Company Ticker: M K L US Equity
Date: 2012-08-09

FINAL

This quarter, redeemable noncontrolling interest balances were marked out by $8.2
million. The adjustment is reported to retained earnings and reduces net income to
shareholders when calculating earnings per share. You can find the earnings-per-share
calculation in Footnote 2 and additional information regarding our contingent obligations
to the noncontrolling shareholders in Footnote 8.
The second item I would like to point out was previously discussed in our First Quarter
conference call and filing but I'd like to remind everyone that we chose to prospectively
adopt the new DAC accounting standards. As of June 30, 2012 we have recognized
approximately $35 million or 3 points of expenses related to the prospective adoption of
the new standards.
Now that we have covered these new items I will review the 2012 financial results. I will
follow the same format in discussing results as in past quarters. I will start by discussing
our underwriting operations followed by a brief discussion of our investment results and
bring the two together with a discussion of our total results.

Bloomberg Transcript

Our total operating revenues grew 12% to $1.4 billion in 2012 from $1.3 billion in 2011. The
increase is due to a 10% increase in revenue from our insurance operations and a 30%
increase in revenue from our non-insurance operations which we refer to as Markel
Ventures.
Moving into the underwriting results, gross written premiums for the six months of 2012
were just under $1.3 billion which is an increase of 9% compared to 2011. The increase in
2012 was due to higher gross premium volume in each of our three operating segments.
Net written premiums were approximately $1.1 billion, up 9% to the prior year. Retentions
were up slightly in 2012 at 89%.
Earned premiums increased 9%. The increase in 2012 was due to higher earned premium
volume in each of our three operating segments. Increases in gross, net, and earned
premiums have all benefited from our recent insurance acquisitions in the Specialty
Admitted segment. Our combined ratio was 93% for the first six months of 2012
compared to 107% in 2011. As a reminder, our 2011 combined ratio included $99 million or
10 points of underwriting losses related to the catastrophe events which occurred last
year in the US, Australia, New Zealand, and Japan.
Setting aside the impact of the prospective adoption of the new DAC accounting
standard in 2012 and the effects of catastrophes in 2011, the improvement in our year-todate combined ratio was due to a lower current accident year loss ratio and to more
favorable development of prior-years' loss reserve within the London Insurance Market
segment compared to the same period in 2011. The improvement in the current accident
year loss ratio was due to lower attritional current year losses in the Excess and Surplus
Line segment and the London Insurance Market segment.
Favorable redundancies on prior-years' loss reserve increased to $191 million or 18 points
of favorable development, compared to $151 million or 16 points of favorable
development in 2011. The increase was primarily due to more favorable development of
Page 3 of 21



Company N ame: M arkel Corp
Company Ticker: M K L US Equity
Date: 2012-08-09

FINAL

prior-years' losses in the London Insurance Market segment. Favorable development on
prior-years' losses in 2012 was primarily on the 2008 and 2009 accident years and
occurred in a variety of programs across our international division.
Now I will discuss the results of our non-insurance operations, which we call Markel
Ventures. In 2012, year-to-date revenues from Markel Ventures were $191 million
compared to $147 million in 2011. Year-to-date net income to shareholders from our noninsurance operations, Markel Ventures, was $400,000 in 2012 compared to $4.7 million in
2011. Revenues from Markel Ventures increased in 2012 as compared to 2011 primarily due
our acquisitions of Baking Technology Systems Incorporated and WI Holdings
Incorporated in late 2011, as well as Havco 2012.
Next, some information on our investment results. Investment income was up 7% in 2012
to just under $144 million. Net investment income for the six months of 2012 included a
favorable change in the fair value of our credit default swap of $12 million, which compares
to $600,000 in 2011. During the First Quarter of 2012, financial markets improved and
credit spreads narrowed, which favorably impacted this credit default swap.

Bloomberg Transcript

Net realized investment gains were $20 million compared to $13 million in 2011. Net
realized gains for the six months of 2012 excluded $1 million of write-downs for other than
temporary declines in the estimated fair value of investments as compared to $5 million in
2011.
Unrealized gains increased $194 million before taxes in 2012 driven primarily by increases
in equity securities. Tom will go into further detail on investments in his comments.
Looking at our total results for 2012, the effective tax rate was 23% in 2012 compared to
an effective tax rate of 14% in 2011.
The increase is primarily due to anticipating a smaller tax benefit related to tax exempt
investment income as a result of projecting higher pre-tax income for 2012 than in 2011.
We reported net income to shareholders of $147 million compared to $39 million in 2011.
Book value per share increased 8% to $380 per share at June 30, 2012 at year-end.
I will now make a few comments on cash flow and the balance sheet. Net cash provided
by operating activities was approximately $105 million for the six months ended June 30,
2012. That compares to approximately $100 million for the same period as 2011.
The increase in net cash provided by operating activities was due to higher cash flows
from underwriting activities as a result of higher premium volumes in each of our three
operating segments. Partially offset by increased claims settlement activity during the First
Quarter of 2012, primarily in the London Insurance Market segment. Investments in cash at
the holding company were approximately $900 million at June 30, as compared to a little
less than $1.2 billion at the end of 2011.
The decrease in invested assets is primarily the result of acquisitions made during 2012.
On July 2, 2012 the Company issued $350 million of 10-year 4.9% unsecured notes for net
proceeds of $347 million. A portion of the proceeds was used to redeem the Company's
Page 4 of 21



Company N ame: M arkel Corp
Company Ticker: M K L US Equity
Date: 2012-08-09

7.5% unsecured senior debentures due August 22, 2046 at a redemption price of $150
million. Remaining proceeds will be used to partially refund the repayment of the
Company's 6.8% unsecured notes due February 15, 2013. At this point I will turn over to
Mike to further discuss operations.

FINAL

Michael Crowley

{BIO 1871008 <GO>}

Thanks, Anne. Good morning, everyone. I am pleased to report that the Second Quarter
North American results were positive from a rate, premium, and underwriting perspective.
When measured against the First Quarter, our North American underwriting segment
achieved better rate results in the Second Quarter with rates increasing 4.5% on average
versus 3.4% in the First Quarter. We believe that a better comparison to the progress
made in our ability to increase rate is to look back at the same period in 2011.

Bloomberg Transcript

Last year, the majority of North American business segments had rate decreases and the
total book generated a minimal increase through the first six months of 2011. We are
making progress. With regard to premium growth, the E&S regions grew by 4.1% bringing
growth year-to-date to 6.1%. Total E&S segment grew by 1.7% for the quarter and 6%
year-to-date, the difference being the growth numbers for the E&S regions in the entire
segment, difference is the impact of exited lines of businesses that were booked in 2011
for the same period.
The Specialty Admitted segment grew 25.5% for the quarter; it was up 18.1% year-to-date
over the same period in 2011. This growth is fueled by the addition of $26 million of
THOMCO premiums and growth in the Markel FirstComp business. Our existing property
and casualty businesses and our agribusiness also were up for the quarter and the year.
Markel American, our personal lines division, generated 5.9% growth for the quarter and
5% year-to-date. The combined ratios for all North American segments improved for the
quarter versus the same period in 2011. The Specialty Admitted segment improved 5
points to 102 from 107; E&S segment improved 5 points as well from to 87 from 92 in
2011.
The THOMCO transition which we closed January 1 of this year continues in a very positive
manner. We still believe that we will book approximately $60 million on Markel paper in
this fiscal year. FirstComp is executing their plan for improved results through price
increases, geographic analysis, and reallocating volume to favorable territories, plus
expense reduction efforts.
Cross-selling of FirstComp is showing improvement with 145 agents completing their
Markel producer agreements, bringing the total count of agents who have initiated this
process to 602. In June, 89 Markel FirstComp agents requested a THOMCO producer
agreement bringing that total to 325 so far this year.
In the E&S segment, binders increased at a higher rate than submissions reflecting some
improvement in the market as well as some benefit from our efforts to cull nonperforming agents and reduce the receipt of submissions that offer little opportunity to
Page 5 of 21



Company N ame: M arkel Corp
Company Ticker: M K L US Equity
Date: 2012-08-09

FINAL

Markel. We completed and released phase two of our broker portal in the E&S division,
which included the addition of more than 120 property and casualty class codes in the
quick quote rate function for rating, quoting, and binding. Across all E&S regions we
conducted a total of 489 agency visits, hosted three producer events, and held
underwriting conferences in four regions.
In addition during the quarter, we were pleased to announce several new promotions of
significance. Jeff Lamb has been with Markel for 11 years serving most recently as Head of
Underwriting in our Midsouth region was promoted to Executive Underwriter for the E&S
division. Evans Nash who has been with Markel for 17 years has assumed the role of
Managing Director, Wholesale Marketing. Evans recently was in charge of our binding
business. He replaces Wendy Hauser, who is transferring back to our Midsouth region to
fill the senior position left over by Jeff Lamb's promotion.
I would like to point out that Wendy just did a terrific job in her role as Managing Director,
Wholesale Marketing and we expect the same results from Wendy in the Midsouth region.
Each of these individuals brings a wealth of knowledge and talent to their respective
positions. Our ability to promote from within is evidence of the depth of talent at Markel.
In summary, we're pleased with the performance in North America in the quarter but we
will not lose sight of the fact that continuous improvement is both necessary and possible.
I would like to turn the call over to Richie Whitt.

Bloomberg Transcript

Richie Whitt

{BIO 7084125 <GO>}

Thanks Mike. Good morning everybody. During the first six months of 2012, Markel
International's gross written premiums grew 7% to $514 million. Significant areas of growth
continue to be in the marine and energy and our catastrophe-exposed property lines
both 3D [ph] and open-market property. We continue to see price increases on
catastrophe-exposed property and marine and energy business.
However, as the years progress, these price increases appear to be moderating to some
extent. Our overall average price increase on renewal business in the first six months of
the year was approximately 5%. CAT property increases have generally been between
the 10% to 20% range and energy has seen low single-digit increases.
All the rest of our lines on the international side are relatively stable, maybe a point or two
up, a point or two down, but pretty stable I would say. So despite solid price increases in
several of the lines of business in the first half of the year, there is still a pretty
competitive market and there is still quite a bit of capacity out there. International's
combined ratio for the first six months of 2012 was 86%.
That includes 3 points of expense related to the adoption of the new deferred acquisition
cost accounting standards that Anne mentioned. As opposed to the significant CAT
losses that we experienced in the first half of 2011, our first six months of '12 results really
include minimal catastrophe losses.

Page 6 of 21



Company N ame: M arkel Corp
Company Ticker: M K L US Equity
Date: 2012-08-09

FINAL

In addition, Markel international's 2012 combined ratio included $86 million of favorable
development on prior-year reserves. This included $18 million of takedown on 2001 and
prior-year reserves. We always strive to establish reserves that are more likely redundant
than deficient at Markel. However the releases we experienced in the first six months are
more than we would normally expect and are, as Anne said, the result of favorable
development across a number of product lines including that 2001 and prior reserve
release that I mentioned.
Want to congratulate William Stovin and the International team on this really strong start to
the year. Our goal for the second half of the year is going to be to continue to build on
this positive momentum, continue to look for opportunities to profitably grow the
international franchise.
Finally, switching gears, I would also like to mention a significant accomplishment for our
IT, finance, actuarial, and information management team. During the Second Quarter we
went live with the first phase of a data warehouse, which includes all of our Excess and
Surplus Lines business. We are already seeing the benefit of being able to better analyze
our Excess and Surplus Lines data.

Bloomberg Transcript

We'll be able to provide our underwriters and product line leaders with significantly better
information about production, profitable classes, classes the need corrective action. We
believe that over time, better access to this information is going to help us gain a
competitive advantage. With that, I would like to turn it over to Tom.

Tom Gayner

{BIO 1896932 <GO>}

Thank you, Richie. As Anne mentioned earlier, book value per share rose to a new record
high of $380 as of June 30. Our comprehensive income so far in 2012 of $279 million
created an increase in book value per share of roughly $28 or 8% during the first six
months of the year. I'm happy with those results, and I hope you are as well. I'm also
especially pleased that those results occurred even though we were not hitting on all
cylinders.
Specifically, while we enjoyed excellent results from our insurance and equity investment
operations, as well as positive returns from our fixed income portfolio, the results at
Markel Ventures were below my expectations.
The fact that we can hit new records in book value and compound capital at the rates we
did, despite not hitting on all cylinders is very encouraging to me. The reality is that it is
highly unlikely that we will ever hit on every single cylinder at once. That said, look at the
returns we have earned given that fact. I am encouraged by what we have built and are
continuing to build at Markel.
We've got more cylinders than we used to and more chances to keep the engine going
forward. We will let the politically minded of you debate whether we built that ourselves or
not, but the numbers seem to indicate that somehow or another, Markel's long legacy of
creating enduring value continues.
Page 7 of 21



Company N ame: M arkel Corp
Company Ticker: M K L US Equity
Date: 2012-08-09

FINAL

As to some details, during the first half the total return on the investment portfolio was
4.5%. Equities enjoyed a return of 9.7%, and fixed income produced a positive overall
return of 2.9%. Markel Ventures consolidated results, however, as I said, were below my
expectations for the first six months. On revenues of approximately $190 million, EBITDA
totaled $9.4 million. This compares to revenues of $146 million a year go and EBITDA of
$9.9 million. As always, a reconciliation of EBITDA to net income is available on the
website.
In the equity portfolio, our focus on high-quality securities paid off. During the first six
months, we earned 9.7% compared to the S&P 500 total return of 9.5%. Over the last 15
years, a longer and more meaningful timeframe, we have outperformed the S&P 500 by
170 basis points per year. We have also outperformed the Barclay's Aggregate Bond
index by 220 basis points per year, which demonstrates the value we add to our
shareholders by investing in stocks.

Bloomberg Transcript

Equities now represent roughly 60% of our total shareholders' equity, up from 55% at
year-end. We continue to steadily and regularly add to or equity investment portfolio and
we expect to continue to do so. Revenues are going up around here, and we've got ideas
for where to invest the money.
In our fixed income operations, we earned a total return of 2.9%. Interest rates moved
lower yet again during the Second Quarter so we over-earned the coupon from our bond
portfolio. Yet again, I continue to be amazed that this is happening and remain ever more
defensively positioned with that portfolio. Duration for the overall bond portfolio is now at
a record low for us of 3. The perverse good news is that the opportunity cost of holding
an ever-shorter duration bond portfolio is going down.
Given the low rate at the front and long end of the curve, we couldn't stretch for yield
even if we wanted to. There just isn't any worthwhile yield out there to be had. As such,
we have a portfolio where the difference is between what one would call cash and
equivalents and fixed income continue to diminish.
That means for all practical purposes, we have a lot of cash and all the options that go
with cash, such as deploying at higher rates of return as time goes by. It also means we
are protecting our balance sheet against a rise in interest rates even more than last
quarter and last year, and I believe that's a good idea.
Finally, let me address Markel Ventures. As I mentioned earlier, we breathe the same air
as everybody else and the continued passage of caution in the overall economy caused
several sales, large ticket capital goods to be pushed out beyond original shipment
schedules. There's also some undeniable pressure on our order books and sales prices.
Additionally and positively, we are undertaking meaningful expansions at several of our
units which means that we are incurring up-front expenses to build for the future.
That said, I am optimistic about the second half of the year. Our current shipment rates
are encouraging, seasonality helps us in the second half, and we should begin to see the
beginning of the pay off in both sales and earnings from some of the major expansions
Page 8 of 21



Company N ame: M arkel Corp
Company Ticker: M K L US Equity
Date: 2012-08-09

FINAL

underway at the Markel Ventures Company. Additionally, we acquired a controlling interest
in HAVCO late during the Second Quarter. Havco is the leading manufacturer of flooring
for the trailers of the 18-wheelers you see out there on the highway.
Subsequent to the end of the quarter we also acquired Tromp, a Dutch baking equipment
company, which will join our AMF bakery operations and IDRECO, a Dutch dredging
manufacturer which joins our Ellicott Dredge operations. These additions should begin to
contribute to our second half results. As we look out over the balance of 2012 and into
2013, I expect that the current run rate of revenues for the Markel Ventures companies
should approximately $600 million and that they should produce double-digit EBITDA on
those revenues. I look forward to reporting those sorts of results to you.

Bloomberg Transcript

Additionally, let me take a few minutes to discuss our culture and history of being very
conservative in our accounting judgment. As you've heard us say, we have a policy of
reserves being more likely to be redundant than deficient You can see the evidence that
we mean what we say in our history of reserve redundancy. During this quarter, new
items, noncontrolling interest Anne referred to earlier in her comments, is yet another
example of what I would consider to be extremely conservative accounting and financial
presentation. And I would like to explain it as I see it economically.
In many of the Markel Ventures acquisitions, we buy less than 100% of the businesses on
day one. In each and every case, agreements with specific valuation mechanisms have
been put in place by which Markel will acquire additional ownership over time and move
towards 100% ownership. When we buy 100% of a business, the price we pay logically
goes directly onto our balance sheet and consolidates into Markel Corporation's financial
statement.
Under accounting rules which are confusing to me, if we buy, say 80% of the business,
that amount goes on the balance sheet as you would expect. When we buy the remaining
20%, that stub amount is expensed as a period expense through the income statement
and doesn't get placed on the balance sheet as an asset.
We've already done this once when we bought the additional 20% interest in AMF that
increased our ownership to 100%. That transaction took place in 2010. With this
noncontrolling interest item, we are essentially putting up a provision against our
comprehensive income and providing for our expectation of what we will pay over the
next several years for the additional minority interest we expect to buy in several of the
Markel Ventures entities.
I'm thankful for my accounting degree, but I never expected to use it like this. I don't think
the treatment follows economic logic, but those are the accounting rules as they currently
exist and we follow them conservatively. For additional discussion of this topic, I
encourage you to read Page 15 of the 2011 Berkshire Hathaway annual report, where Mr.
Buffett writes about this exact issue in conjunction with the ongoing acquisition of
additional percentage ownership of his Marmon subsidiary.

Page 9 of 21



Company N ame: M arkel Corp
Company Ticker: M K L US Equity
Date: 2012-08-09

FINAL

I apologize for spending this kind of time on these subjects as well as subjecting you to
my philosophy about them, and I appreciate our dedicated and hard-working accountants
who spend a great deal of time and diligent effort to understand and comply with the
increasing codification of accounting rules. But I think its worth covering. Unless we all
understand and appreciate what goes into comprehensive income, accounting treatment,
and total economic returns, we won't fully understand and be able to reasonably measure
the economics occurring at Markel.
Over the years, investors have accorded Markel a premium multiple compared to many of
our peers. I think this is the result of our history of producing excellent long-term returns,
as measured by the total comprehensive returns for the business as well as having
confidence in the conservatism and dependability of our accounting. A premium multiple
also comes from the belief and faith that will continue to be able to allocate our capital
well in the future and earn above-average returns from doing so as we have in the past.
What makes me so excited is that we have more process and opportunity to effectively
allocate capital than ever before in our history. We have the imagination, the creativity, and
the discipline of execution to make our dreams real. I like our hand. We are now all
delighted to discuss our comprehensive results that we are reporting today and we hope
that you share our optimism about the future.
With that, Manny, if you'd be so kind as to open the line for your questions. Thank you.

Bloomberg Transcript

Questions And Answers
Operator
Thank you. Ladies and gentlemen, we will now be conducting a question-and-answer
session.
(Operator Instructions).
Mark Hughes, SunTrust.

Q - Mark Hughes

{BIO 1506147 <GO>}

In terms of the pricing, it sounds like things are getting better in North America. In talking
about the Marine and Energy and Cat-exposed properties you did suggest that the pace
of improvement has moderated recently, let's say. What do you think about the broader
P&C environment in the US? Is it moderating as well? Or are you continuing to see
progress?

A - Richie Whitt

{BIO 7084125 <GO>}

Mark -- Richie; how are you doing?

Page 10 of 21



Company N ame: M arkel Corp
Company Ticker: M K L US Equity
Date: 2012-08-09

FINAL

The thing I think you have to recognize is, those lines of business in London, they probably
started strengthening before some of the other lines, some of the US lines as an
example. The price increases we're getting in energy and the price increases we're
getting on the Cat-exposed stuff -- that's on top of price increases we were getting last
year. So it doesn't surprise me, given that there is still a decent amount of capacity out
there, that we are not going to continue to see increasing price increases, unless we start
to have events or something else happens. Capacity starts to leave.
That doesn't surprise me a lot. I think what Mike would tell you and what Mike said about
the Second Quarter is, actually we saw some incremental improvement in the price
increases in the US.

A - Michael Crowley

{BIO 1871008 <GO>}

Yes, I agree, and I don't want anybody to think that the world isn't still competitive out
there, because it is. But so far we have been working hard to get rates, and we have
been successful in doing it. And I think you also have to keep in mind that the way we
price our products -- a lot of times we are not the cheapest guy out there, so we're
starting from a different position than maybe some of our competitors are that might be
reporting larger rate increases. But the market is fairly consistent; there are still some
lines, like the medical malpractice, that are very competitive, but we have been making
progress.

Q - Mark Hughes

{BIO 1506147 <GO>}

Bloomberg Transcript

Got you.
The systems you talked about, how broadly are those going to be implemented? Is that
across most or all product lines? And how much more granular or timely is your
information going to be?

A - Tom Gayner

{BIO 1896932 <GO>}

Right now, it's across really the wholesale division. So it's all the systems, it aggregates all
the information up there. Over time, we would love to expand that to the specialty areas
as well. London has their own systems in terms of looking at their information. It's a good
bit more granular than what we have had in the past, and we were having to do a lot of
work to combine information.
So we're pretty excited about it. We are able to give our underwriters and product line
guys a lot more to work with now to manage their portfolios. I think its a real step forward
for us.

Q - Mark Hughes

{BIO 1506147 <GO>}

Thank you.

Operator
Page 11 of 21



Company N ame: M arkel Corp
Company Ticker: M K L US Equity
Date: 2012-08-09

Jay Cohen, Bank of America.

Q - Jay Cohen

{BIO 1498813 <GO>}

FINAL

Couple questions -- on the E&S business, the premium gross slowed pretty considerably
from the First Quarter growth rate. I'm wondering what is behind that?

A - Tom Gayner

{BIO 1896932 <GO>}

We did have an earlier close this year that we did last year. That had a little bit of an
impact on it, I am not going to quantify that because we will just have to deal with that
next quarter if we did. But I think the growth rate, we are comfortable with. As I pointed
out, we have been working hard to reduce the number of -- I don't want to use the word
useless -- but the number of submissions that we get, where in reality we have very little
opportunity to write business, and we have been more focused on spending our time on
stuff that we really want to write. And we're starting to make some incremental progress
there.
Other than that, we feel very good about where we are in the E&S segment, we feel very
good about our submission plug, we feel very good about our buying rates, and are very
optimistic about the rest of the year.

Q - Jay Cohen

{BIO 1498813 <GO>}

Bloomberg Transcript

I guess it does jump around a bit quarter to quarter. If I look at the first half results, is that
a better indication?

A - Tom Gayner

{BIO 1896932 <GO>}

Probably.

A - Richie Whitt

{BIO 7084125 <GO>}

Jay, this is Richie. As Mike mentioned, we are constantly adding products; at the same
time we're constantly looking at products that aren't performing and we will discontinue
those if they are not performing. We have a little bit of noise in the numbers around some
of those exited lines. There is a little bit of lumpiness between the first and Second
Quarter. But I think looking at the growth rate over the first six months is probably a good
way to look at it.

A - Michael Crowley

{BIO 1871008 <GO>}

Yes, I agree.

Q - Jay Cohen

{BIO 1498813 <GO>}

Great -- and same question in London. I'm not sure if currency played a role here, but the
growth rate had been double-digit and it slowed down to about 2% on a written basis.

A - Tom Gayner

{BIO 1896932 <GO>}
Page 12 of 21



Company N ame: M arkel Corp
Company Ticker: M K L US Equity
Date: 2012-08-09

FINAL

We've got some seasonality, obviously, to the book in London. Where we're getting a lot
of the price increases as well as we were writing more premium, is the Cat-exposed
Business in January 1, and April 1 are big dates for that, but January 1, in particular. So
there's a little bit of seasonality there. But again, I would probably look at the six-month
growth rate, and that's probably a pretty good policy.

Q - Jay Cohen

{BIO 1498813 <GO>}

That is helpful.
And the last question -- the tax rate, just given where you made your money, and a lot of
it came in the underwriting side, obviously, given the huge reserve release -- the tax rate
to me seemed a little low. And I could talk off-line about this, but is there anything in the
tax rate that distorted things at all this quarter?

A - Anne Waleski

{BIO 16735457 <GO>}

No, nothing unusual, and I'm happy to take it up with you off-line, but there is nothing odd
in it.

Q - Jay Cohen

{BIO 1498813 <GO>}

Okay, we will follow up on that than. Thank you.

A - Tom Gayner

{BIO 1896932 <GO>}

Bloomberg Transcript

Thanks, Jay.

Operator
David West, Davenport.

Q - David West

{BIO 1838548 <GO>}

One for each of you -- first, Anne, on the accounting side, on the prospective adaptation
of the new DAC expense accounting, I think earlier you estimated about a $43 million
impact for the full-year. Is that still a good estimate?

A - Anne Waleski

{BIO 16735457 <GO>}

That's correct.

Q - David West

{BIO 1838548 <GO>}

Great; and that will still be primarily Third Quarter, more Third Quarter than Q4?

A - Anne Waleski

{BIO 16735457 <GO>}

Right. It is front-loaded. In the first half of the year, you'll start to see the quarter number
come down and the whole year should be about $43 million.

Page 13 of 21



Company N ame: M arkel Corp
Company Ticker: M K L US Equity
Date: 2012-08-09

Q - David West

{BIO 1838548 <GO>}

Great. And Tom, when I look at the cost basis of the portfolio, June 30 versus year-end, it
looks like fixed income basis is down, short-term down, but equity up. Is that more of a
conscious acceleration of monies toward the equity portfolio?

FINAL

A - Tom Gayner

{BIO 1896932 <GO>}

There's a mild acceleration, but I think actually if you look at that pattern, you'd find since
the First Quarter of 2009 we have steadily dollar cost-averaged our way into bigger and
bigger equity positions; and the way you could really track that if you wanted to, is to look
at exactly that -- the cost basis. And that's a reasonable number to look at, because our
turnover -- compared to the high-frequency guys at night, we are the low-frequency guys
at Markel -- our turnover statistics [ph] are very low, so that would be a relatively accurate
way of seeing the dollars we are putting in the equity portfolio.

Q - David West

{BIO 1838548 <GO>}

I guess it's also a reflection of the alternatives with the low interest rate environment, as
well.

A - Tom Gayner

{BIO 1896932 <GO>}

Bloomberg Transcript

Yes, but I would say it's really more driven by the fact that we see equity opportunities.
We think that's where we get the best, long-term, total return over time when we have
the balance sheet and the business will to do it.

Q - David West

{BIO 1838548 <GO>}

Great. And Mike -- turning to the FirstComp, the premiums written there have increased
year-over-year; the losses that have been recorded this year are also higher than last
year. Are those still running within your range of expectations?

A - Michael Crowley

{BIO 1871008 <GO>}

Yes, they are, David. And FirstComp, as I said, we have given FirstComp a plan and they
are executing the plan right on target with our expectations. As I mentioned in my
comments, they're getting rate increases. There focusing on a geographic analysis,
moving to areas where there is more opportunity for better business and moving out of
some areas where historically the performance has not been good.
Last year we added a couple states. We added Alaska, we added Louisiana. They're
focused on their expense reductions. So we are very comfortable that they are executing
exactly like we want them to.

Q - David West

{BIO 1838548 <GO>}

Are you continuing to move away from California?

A - Michael Crowley

{BIO 1871008 <GO>}

Page 14 of 21



Company N ame: M arkel Corp
Company Ticker: M K L US Equity
Date: 2012-08-09

Parts of California, but there are parts of California that we are comfortable with. And they
are restructuring their book in California.

Q - David West

{BIO 1838548 <GO>}

FINAL

Very good.
And Richie -- on the international side, you mentioned in the Q that 2008/2009 were the
years for the favorable development. You mentioned it extended across a lot of product
lines, but could you add a little bit more color to that? Where there any particular lines that
made a meaningful contribution to that favorable development?

A - Richie Whitt

{BIO 7084125 <GO>}

Bloomberg Transcript

Yes, David, it really was across product lines there. I know that it sounds like a copout, but
it really was. I think part of the issue is, we have been very concerned about how the
market was declining in those years, so we were very cautious in how we established the
reserves. And we have had some pretty darn good developments the last few quarters. It
really was pretty much across.
It was Professional Liability; there was actually some in Property; it was Marine and Energy.
And then, of course, there were some 2001 and prior, where we have been incredibly
cautious with those reserves, because is that it is the old legacy business that came to us
when we purchased Terra Nova, so we have been very cautious with those, and got to
the point where we could release some of those reserves. It was a really good quarter.
The only thing I would they is, it was a really good quarter, and I wouldn't take that into
numbers in the third and Fourth Quarter.

Q - David West

{BIO 1838548 <GO>}

Thanks very much.

Operator
Scott Heleniak, RBC.

Q - Scott Heleniak

{BIO 15171212 <GO>}

I was just wondering -- the ThomCo book, you said you expect $60 million in premium this
year; and was wondering if you had a target you might be able to share for next year, for
2013? Are you going to get to the $160 million?

A - Tom Gayner

{BIO 1896932 <GO>}

The $60 million is a number that we feel we will book this year. Obviously ThomCo writes
a lot more business than that, but we are also transitioning the business to Markel paper
from other carriers, and so the ability to forecast exactly what the slippage might be there
or something is not something we want to do at this point. But their volume was
considerably more than $60 million.

Page 15 of 21



Company N ame: M arkel Corp
Company Ticker: M K L US Equity
Date: 2012-08-09

Q - Scott Heleniak

{BIO 15171212 <GO>}

FINAL

Okay. And just want to touch on the Markel Ventures, Tom, you mentioned some
investments that you're making there. Just wondering if you could elaborate on some of
the areas. Is that across the board, or was there a few specific divisions you can talk
about?

A - Tom Gayner

{BIO 1896932 <GO>}

It's across-the-board. In each of the companies, there's some pretty dramatic
opportunities to expand. There are competitors who have more leveraged balance
sheets and are having competitive difficulties and give us the opportunity to pick up some
business. We are undergoing fairly dramatic physical expansions in a lot of the different
business units.

Q - Scott Heleniak

{BIO 15171212 <GO>}

Okay. And just one other one on Markel Ventures -- you acquired two Dutch companies in
the quarter. Was that a one off ? Or should we continue to expect to see international
acquisitions at Markel Ventures?

Bloomberg Transcript

A - Tom Gayner

{BIO 1896932 <GO>}

My insurance colleagues were hanging around Holland, so we were in the neighborhood.
That just happened to be the case. The Markel Ventures Company, in fact -- Ellicott is the
most dramatic example -- but they do 80% of their revenue outside of the US. It's a
global company and has been so for decades. AMF, at the time we purchased it back in
2005, might have been 10% or 15% international. Probably that's more like 35% or 40%
these days. A lot of these businesses are seeing international expansion opportunities,
and we don't plan on geographies; what we plan on is trying to find what the best
business opportunities are and going there.

Q - Scott Heleniak

{BIO 15171212 <GO>}

Okay, that is helpful. Explained that correlation there.
The other one is -- just wanted to ask about the foreign government exposure you have.
Can you remind us what exactly you have most concentrated, which countries; and
whether you have reduced exposure to any of those countries at all this year or whether
that has changed much this year?

A - Richie Whitt

{BIO 7084125 <GO>}

The good news is that the traders haven't really changed, because we did not have too
much in the way of countries where we didn't want to have exposure that you read about
in the headlines now. What we do is, we try to match the liability of our insurance policies,
and we take in premiums in euros or sterling, and we are going to make a claims payment
in one of those currencies. We buy bonds in that currency to the best of our ability, to
match that liability and we buy the very highest credit quality we can, and we take the
results as they are. We don't try to engineer a result that would be better than the natural
circumstances we create.
Page 16 of 21



Company N ame: M arkel Corp
Company Ticker: M K L US Equity
Date: 2012-08-09

Q - Scott Heleniak

{BIO 15171212 <GO>}

Okay, thanks a lot.

FINAL

A - Tom Gayner

{BIO 1896932 <GO>}

Let me come back to your ThomCo question. I'm going to give you a little more clarity.
When we acquired ThomCo, the prior year, they had placed over $160 million of premium.
There are a couple of programs that ThomCo wrote -- a couple of their smaller programs
-- that we probably won't move to Markel paper because it's a different underwriting
appetite than we have. That could give you little more clarity on ThomCo.

Q - Scott Heleniak

{BIO 15171212 <GO>}

Okay, thanks.

Operator
Ron Bobman, Capital Returns.

Q - Ron Bobman

Bloomberg Transcript

I had a question on E&S and Aspen. On the E&S front, I was wondering if -- you touched
on, you're happy with your app counts and your buying rates. Would you give us some
metrics of how those two stats compared Q2 this year versus Q1 this year?

A - Tom Gayner

{BIO 1896932 <GO>}

Slightly better. Not a lot of difference.

Q - Ron Bobman
Okay marginally better, but not all that dramatic.
I had a question about Aspen and changes there. Will Aspen in California -- if you could
share the California rate changes for Aspen of late, and --

A - Tom Gayner

{BIO 1896932 <GO>}

I don't have those in front of me. We'd be happy to talk about it. It's not inconsistent with
their rate increases elsewhere, which has been in the neighborhood of around 5%.

Q - Ron Bobman
Okay, and should we think of Aspen shrinking this year compared to last?

A - Tom Gayner

{BIO 1896932 <GO>}

No. You mean in California?

Page 17 of 21



Company N ame: M arkel Corp
Company Ticker: M K L US Equity
Date: 2012-08-09

Q - Ron Bobman
Either way. I was thinking California.

A - Tom Gayner

{BIO 1896932 <GO>}

FINAL

At this point, they are not shrinking, in total.

Q - Ron Bobman
Understood. Thank you, very much.

Operator
(Operator Instructions).
Meyer Shields, Stifel Nicolaus.

Q - Meyer Shields

{BIO 4281064 <GO>}

Two quick questions, if I can. One, on the International or London side, we saw the
expense ratio up 300 basis points or so, sequentially. Is that a consequence of the
reserve releases?

A - Tom Gayner

{BIO 1896932 <GO>}

Bloomberg Transcript

It's two things. It's the deferred acquisition account -- and how many points is that?

A - Anne Waleski

{BIO 16735457 <GO>}

In London?

A - Tom Gayner

{BIO 1896932 <GO>}

In London. We will find that.
The other thing is with the significant reserve releases, we've got bigger bonus accruals
going up. It's interesting there -- you have prior year reserve releases, but there is no such
thing as prior-year bonus expense that goes against this year's expense ratio. So little bit
of a mismatch when you think about it.

Q - Meyer Shields

{BIO 4281064 <GO>}

Okay. And when we calculate the tax rate for the London segment, should we be using
the UK corporate tax rate?

A - Tom Gayner

{BIO 1896932 <GO>}

Say that one again I'm sorry?

Page 18 of 21



Company N ame: M arkel Corp
Company Ticker: M K L US Equity
Date: 2012-08-09

Q - Meyer Shields

{BIO 4281064 <GO>}

Yes, if we try and break up the expected tax calculation based on the geographic
(technical difficulty), is that reasonable? Should we use UK corporate tax rates for the
London insurance market segment?

FINAL

A - Tom Gayner

{BIO 1896932 <GO>}

No, the way the US works is, it taxes you at 35% on everything you make in the world.
Really, the thing you should think about, probably, is, we pretty much have a 35% rate
other than our union portfolio, which is not taxed.

Q - Meyer Shields

{BIO 4281064 <GO>}

Okay. Great, thank you.

Operator
Adam Klauber, William Blair.

Q - Adam Klauber

{BIO 1494359 <GO>}

What is your overall loss trend in workers comp for 2012? And what's that trend in
California, workers comp?

Bloomberg Transcript

A - Tom Gayner

{BIO 1896932 <GO>}

I don't have those with me. I don't have that information here.

Q - Adam Klauber

{BIO 1494359 <GO>}

Okay, fine. As far as ThomCo -- are those programs growing right now? The programs
you're keeping, the main ones?

A - Tom Gayner

{BIO 1896932 <GO>}

They're pretty stable. During the transition, we are being very careful and trying to be
efficient at what we're doing, because we are transitioning from another company's
paper to our paper, which requires notices and everything else. But they are very stable.

Q - Adam Klauber

{BIO 1494359 <GO>}

Okay, okay. And then, finally, on the Lloyd's reserve release -- you've had significant
redundancies, but this is a bigger number. Could you do some review or -- why is the
number that big this quarter?

A - Michael Crowley

{BIO 1871008 <GO>}

Really, we didn't do anything differently. Like I said, I think we were probably, if anything,
been fairly cautious the last few years, given the decline in the market. In 2008 and 2009
have gotten to an age now where you can believe what you are seeing in terms of

Page 19 of 21



Company N ame: M arkel Corp
Company Ticker: M K L US Equity
Date: 2012-08-09

development. That really drove it more than anything. We are very consistent in terms of
how we work with reserves, and put up the margin in safety in terms of our reserves.
Nothing really changed other than just, we have gotten to a point on those two accident
years where you can believe what you are seeing.

FINAL

Q - Adam Klauber

{BIO 1494359 <GO>}

Okay, thank you very much.

A - Tom Gayner

{BIO 1896932 <GO>}

I want to just emphasize one point about the reserve discussion. We're talking about
geography on the right-hand side of the balance sheet in terms of accounting, whether
it's in the loss reserve or retained earnings by the time reserves are released. The good
news is, that over on the left-hand side of the balance sheet -- the assets -- the number is
unchanged.
The cash was collected a long time ago. It's in the investment portfolio, it's making
money, no matter what geography you have it on the right-hand side of the balance
sheet. I think that's a fundamentally important point that goes into the comprehensive
economic thinking of the way we run things around here.

Q - Adam Klauber

{BIO 1494359 <GO>}

Bloomberg Transcript

Great, thank you.

Operator
Thank you. We have no further questions in the queue at this time. I would like to turn the
floor back over to Management for any closing remarks.

A - Tom Gayner

{BIO 1896932 <GO>}

Thank you, very much, we are glad you joined us. We look for to seeing you again soon.
Thanks; goodbye.

Operator
Ladies and gentlemen, this concludes today's teleconference. You may disconnect your
lines at this time. Thank you for your participation.

This transcript may not be 100 percent accurate and may contain misspellings and other
inaccuracies. This transcript is provided "as is", without express or implied warranties of
any kind. Bloomberg retains all rights to this transcript and provides it solely for your
personal, non-commercial use. Bloomberg, its suppliers and third-party agents shall
have no liability for errors in this transcript or for lost profits, losses, or direct, indirect,
incidental, consequential, special or punitive damages in connection with the
Page 20 of 21



Company N ame: M arkel Corp
Company Ticker: M K L US Equity
Date: 2012-08-09

Bloomberg Transcript

FINAL

furnishing, performance or use of such transcript. Neither the information nor any
opinion expressed in this transcript constitutes a solicitation of the purchase or sale of
securities or commodities. Any opinion expressed in the transcript does not necessarily
reflect the views of Bloomberg LP.  COPYRIGHT 2022, BLOOMBERG LP. All rights
reserved. Any reproduction, redistribution or retransmission is expressly prohibited.

Page 21 of 21

